Bipartite geminiviruses, such as squash leaf curl virus (SqLCV), encode two movement proteins (MPs), BR1 and BL1, that are essential for viral movement in and subsequent infection of the host plant. To elucidate the biochemical functions of these MPs and define their respective contributions to viral infection, we have generated transgenic Nicotiana benthamiana plants expressing SqLCV BR1 and BL1. Transgenic plants expressing BR1 or a truncated BL1 were phenotypically indistinguishable from wild-type N. benthamiana. In contrast, transgenic plants expressing full-length BL1, alone or in combination with BR1, were strikingly abnormal both in their growth properties and phenotypic appearance, with leaves that were mosaic and curled under, thus mimicking typical SqLCV disease symptoms in this host. BL1 was localized to the cell wall and plasma membrane fractions, whereas BR1 was predominantly in the microsomal membrane fraction. These findings demonstrate that expression of BL1 in transgenic plants is sufficient to produce viral disease symptoms, and they further suggest that BL1 and BR1 carry out distinct and independent functions in viral movement.
INTRODUCTION
How plant viruses move from the original site of infection to the surrounding cells and systemically invade the plant tocause disease is an important question in plant cell biology as well as in plant virology. Examination of this question has begun to provide insight into the interactions of plant viruses with their hosts and how their movement may alter or modify cellular connections in the host plant.
Plant viruses encode movement proteins (MPs), nonstructural proteins essential for infection that do not affect viral replication or encapsidation (Atabekov and Dorokhov, 1984; Hull, 1991) . The best-characterized protein of this type is the 30-kD MP of tobacco mosaic virus (TMV) (Meshi et al., 1987) . The 30-kD MP is a sequence-nonspecific nucleic acid binding protein (Citovsky et al., 1990) , which has been shown to alter the size exclusion limit of plasmodesmata of nonvascular cells (Deom et al., 1990; Ding et al., 1992) . In vitro and in vivo studies have led to a model for the cell-to-cell spread of TMV in which the MP binds to the viral single-stranded RNA (ssRNA) genome, flattening it into an elongated structure and targeting it to the plasmodesmata, where it also acts to increase the size exclusion limit and thereby facilitate passage of the ribonucleoprotein particle through the cell wall (Citovsky et al., 1992) . This model has become the paradigm for the investigation of MP function in other plant viruses that have an RNA genome and/or RNA replicative intermediates.
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Geminiviruses are strikingly different in severa1 respects from other plant viruses, including TMV. First, the viral genome consists of covalently closed circular ssDNA (Goodman, 1981) . This poses two unique problems for viral movement: (1) a nuclear, rather than a cytoplasmic, compartmentalization of the viral genome necessitates transport of the viral genome andlor virions into and out of the nucleus, and (2) a DNA rather than an RNA binding protein may be required. A second distinctive feature of geminiviruses is their tissue specificity. Geminiviruses are generally phloem limited, a property that is shared with the luteoviruses but not with TMV and other plant viruses being intensively studied (Goodman, 1981; Matthews, 1991) . This raises questions concerning the potentia1 function of viral MPs in different cell types and their role in viral tissue and host specificity. Finally, bipartite geminiviruses encode two w3O-kD MPs, named BR1 and BL1 (Lazarowitz, 1992) , with no striking homologies to other viral MPs. This suggests that BR1 and BL1 may have functions and/or protein-protein interactions distinct from those of other viral MPs.
Because of these differences, we have begun to characterize the BR1 and BL1 proteins from squash leaf curl virus (SqLCV), a member of the bipartite subgroup of geminiviruses. Two closely related SqLCVs nave been cloned and characterized, SqLCV-E (extended host range) and SqLCV-R (restricted host range) (Lazarowitz, 1991; Lazarowitz and Lazdins, 1991) . SqLCV-E is highly infectious in a broad range of hosts, which include pumpkin, squash, green bean, and Nicotianabenthamiana (hereafter given as tobacco). SqLCV-R is also highly infectious in tobacco but is less infectious in the other hosts.
As typical bipartite geminiviruses, SqLCV-E and SqLCV-R each have two -2.7-kb genomic DNA components, both of which are essential for systemic infection. The A component encodes the viral coat protein (AR7 gene) in addition to an essential viral replication protein (AL7 gene) and regulatory proteins (AL2 and AL3 genes). The B component encodes the two viral MPs, BR1 and BL1 (Lazarowitz, 1992) . A study of host range determinants in SqLCV has shown that similar to TMV (Meshi et al., 1989) , the geminivirus MPs are important determinants of viral host range properties (Lazarowitz, 1991) . Analysis of the bipartite tomato golden mosaic virus (TGMV) has also suggested that viral MPs play a role in determining the appearance of disease symptoms (von Arnim and Stanley, 1992) .
To investigate the functions of the geminivirus MPs, we constructed transgenic tobacco plants expressing SqLCV-E BR1 and BL1 either singly or together. Tobacco was chosen as a fully permissive host for viral infection (Lazarowitz and Lazdins, 1991) . As reported here, our characterization of independent lines for these three different transgenic genotypes demonstrates that plants expressing BR1 are phenotypically indistinguishable from wild-type tobacco, whereas plants expressing BL1 mimic geminivirus disease symptoms in this host. Subcellular fractionation studies show that BR1 localizes primarily to the cell microsomal membrane fraction. BL1 partitions with the plasma membrane and a crude cell wall fraction, whereas BR1 is not present to any great extent in these fractions under the conditions used. These results suggest that BR1 and BL1 may perform independent functions in viral movement.
RESULTS

Genetic and Phenotypic Characterization of Transgenic Lines
To construct transgenic tobacco lines expressing SqLCV-E BR7 or BL7, either singly (hereafter BR7 plants or BL7 plants) or together (hereafter BL7::BR7 plants), we utilized an Agrobacterium plant transformation vector into which we could clone one or two separate expression cassettes, as shown in Figure  1 (see also Methods). For plants expressing only BL7 or only BR7, transcriptional fusions of BR7 or BL7 under the control of the cauliflower mosaic virus (CaMV) 35s promoter (Odell et al., 1985) were made by directly cloning each gene with its own translational initiation and termination signals into pMON530 (Rogers et al., 1987) (Figures 1A and lB) , thereby generating pSQBRlE and pSQBLlE ( Figure 1C ). The insertion of two separate expression cassettes was accomplished by constructing a transcriptional fusion of the BR7 gene to place it behind the enhanced CaMV 35s promoter in pMON921 (Kay et al., 1987) , followed by insertion of this expression cassette into the unique Notl site in pSQBLlE ( Figure 1C ; see Methods) to generate pSQBL1::BRlE. Each of these three expression vectors was then transformed into explants of tobacco and regenerants were selected based on resistance to kanamycin (kan? (Rogers et al., 1986b) .
As summarized in Table 1 , 13 to 20 separate lines were characterized for each transformed genotype. The genotype of each transformed line was verified by polymerase chain reaction (PCR) amplification of genomic DNA from primary transformants (T,) and F1 progeny, using primers specific for pMON530 o1 pMON921 expression cassette sequences flanking the cloning site, followed by DNA gel blotting and hybridization with gene-specific probes. As shown in Figure  2 , an amplified PCR product of the expected size (-1 kb) was detected in each line, and hybridization with BR7-or BL7-specific probes confirmed the identity of the inserted transgene(s).
Further genetic characterization of these transgenic lines included segregation analysis of the kanr marker contained on the pMON530 vector and analysis of genomic DNA on DNA gel blots. In most of the lines, kanr segregated in the F1 seedlings as a dominant Mendelian trait with a ratio of 3:l or higher of kanamycin-resistant (kanr) to kanamycin-sensitive (kans) plants, the higher ratio being indicative of insertions at multiple loci (data not shown). In a few lines, the segregation ratio of kanr:kans plants was less than 3:l. This was found to correlate with a reduced germination rate, which we attribute to a detrimental genomic location of the pMON530 insert. Genomic DNA gel blots were used to confirm the independence of the different transgenic lines and to determine the structure at the integrated site(s) (data not shown). Thus, the phenotypes of the different lines, as described below, are due to the particular SqLCV-E gene inserted into the plant genome and not the particular site of insertion.
As shown in Figure 3 and summarized in Table 1 , striking phenotypic differences were evident among the different transgenic lines in both the primary T1 transformants and F1 progeny. Lines containing only BR7 were phenotypically normal in every aspect. These plants grew and matured at a normal rate, were fully fertile, and were indistinguishable in appearance from wild-type tobacco (compare Figure 3C to 38). Two BR7 lines were slightly mosaic (Table 1) . In marked contrast to the BR7 lines, both BL7 and BL7::BR7 lines exhibited phenotypes that resembled SqLCV disease symptoms in tobacco (Table 1; Figures 3A, 3D , and 3E). This symptomatic phenotype included a characteristic mosaic pattern and curling under of the leaves (epinasty). In several cases, the plants were also stunted and bushy, with many lateral branches originating from the base of the plant. The plants displaying symptoms also exhibited other striking growth defects. Compared to wildtype tobacco, BL7 and BLkBR7 plants were slow to shoot and slow to root (several weeks to months longer than BR7 or wildtype plants), and many did not establish well-developed roots. Correlating with this slow pattern of growth and development was a decrease in fertility. Although most lines did set normal numbers of flowers, a majority of the seed pods were empty. In extreme cases associated with the most severe phenotypes, growth and symptomatic phenotype of these transgenic plants cosegregated with the kan' marker as a dominant Mendelian trait (data not shown). Based on DNA gel blots of genomic DNA, the number of inserts did not appear to correlate with the severity of the phenotype (data not shown). In the comparison of the T-i transgenic lines (Table 1) , it appeared that a greater number of BL1::BR1 plants displayed a mosaic leaf phenotype as compared to the BL1 lines. Although this may suggest that the presence of BR1 enhances the BL1 phenotype, further analyses will be necessary to confirm this observation.
To further demonstrate the role of BL1 in the production of this SqLCV diseaselike phenotype, we constructed ABL7 transgenic tobacco expressing only the N-terminal 193 amino acids of the BL1 protein (see Methods). Of the 16 kan' PCR positive lines, none developed the epinastic or mosaic traits (Table  1) characteristic of the transgenic lines expressing the fulllength BL1. All of the AB/.7 lines grew at rates comparable to wild-type (untransformed) tobacco and were indistinguishable from wild-type tobacco in all aspects ( Figure 3F ). These results demonstrated that the expression of the full-length BL1 protein is sufficient to produce the SqLCV diseaselike phenotype in transgenic plants.
One line, BL1::BR1-457, derived from the BL1::BR1 transformation was kan' but phenotypically normal. PCR analysis showed that neither BR1 nor BL1 was present in this line (Figure 2, lanes 9 and 10). Genomic DNA gel blot analysis demonstrated that BL1::BR1-457 carries a partially deleted pMON530 insert (data not shown). This further supports our conclusion that expression of BL1 is responsible for the production of SqLCV disease symptoms in these transgenic plants.
Expression of BL1 and BR1 Genes in Transgenic Plants
To examine the expression of the BL1 and BR1 genes in the transgenic plants, total RNA was isolated from T, and FT plants and hybridized with BR1-and BL1-specific probes. As shown in Figure 4 , the BR1 probe hybridized with a 1.1-kb transcript in BR1 and BL1::BR1 plants. This transcript was not present in control samples of untransformed (data not shown) or BL1 plants (Figure 4) . Importantly, the phenotypically normal BR1 lines were found to express appreciable amounts of BR1 RNA. In some cases, these levels were significantly higher than those found in symptomatic BLT.:BR1 plants ( Figure 4 ). For example, the BR1-31 line had the highest accumulation of BR1 RNA, far greater than any BLT.-.BR1 plant, yet it showed no aberrant phenotype and was indistinguishable from wildtype tobacco in growth rate and fertility. The lower level of BR1 RNA in the BLT.-.BR1 plants may be due to a positional effect on the downstream CaMV 35S promoter that controls BR1 expression. Whatever the explanation, the expression of BR1 does not correlate with any visible phenotype.
In contrast to the pattern of BR1 expression, the accumulation of BL1 RNA does appear to correlate with symptom appearance in the transgenic plants. The BL1 probe specifically hybridized to a 1.3-kb RNA that was present in all symptomatic BL1 and BL1::BR1 plants tested (Figure 4 , bottom panels). In the BL1 plants, the severity of the symptomatic and aberrant growth phenotypes paralleled the RNA levels. T, plants such as BL1-8 and BU-12, which had the highest levels of BL1 RNA, exhibited the most dramatic leaf curl (Figure 4) . This pattern was also observed in young F, plants from a number of BL1 lines. BL1-30 and BL1-31 exhibited the most severe leaf curl of the lines examined, and, accordingly, they had the highest accumulation of BL1 RNA (Figure 4) . Thus, the presence and overall levels of BL1 RNA correlated with the appearance of SqLCV-like phenotypes in the transgenic plants. The phenotypically normal AB/.7 plants expressed appreciable levels of RNA, comparable to the BL1 transcript levels found in the symptomatic BL1 plants (Figure 4 ; data not shown). This again demonstrates that the expression of full-length BL1 is necessary for the SqLCV diseaselike phenotype in the transgenic plants.
Expression and Subcellular Localization of BL1 and BR1 Proteins
Subcellular fractionation of plant tissue expressing the TMV 30-kD MP has shown that this protein, although present in the 
membrane and soluble fractions, also accumulates in the cell wall fraction (Deom et al., 1990; Berna et al., 1991) . We employed a similar scheme to examine the localization and accumulation of the SqLCV-E BR1 and BL1 proteins in our transgenic lines. Differential centrifugation of plant extracts and treatment with denaturing agents were used to generate three protein-containing fractions: soluble protein (S30), crude cellular membrane (P30), and cell wall-associated proteins (P1). The presence of BR1 and BL1 in each fraction was detected by protein immunoblotting using polyclonal antisera generated against BR1 or BL1 expressed in bacteria (see Methods Figure 5 , BL1 protein was detected as a series of bands migrating between ~30 and 35 kD in extracts from both BL1 and BLT.-.BR1 transgenic plants. These bands were not present in control extracts ( Figure 5A , lane 1), and they were not detected by the preimmune sera (data not shown). The predicted size of the BL1 protein is 33 kD; however, BL1 expressed in baculovirus-infected Sf9 insect cells produces a similar pattern of bands to that of the extracts from transgenic BL1 and BL1::BR1 plants ( Figure 5B , lane 1 compared to lanes 2 and 3; also Figure 5A , lanes 2 to 4). The presence of multiple, closely migrating bands near this size could be due to post-translational modification of BL1. Some of these bands may also be due to partial degradation of BL1. Whatever the explanation, it appears that the same alterations occur in the Sf9 insect cells as in the transgenic plants. The series of BL1 bands was found in the membrane (P30) fraction and also in the cell wall (P1) fraction in extracts from both BL1 and BLT.-.BR1 plants ( Figure 5A , lanes 2 and 3; Figure 5B , lanes 2 and 3). A lower amount of BL1 was also detected in the soluble S30 fraction. Extracts of ABL7 plants were tested on protein immunoblots with the anti-BL1 antibodies; however, no consistent bands corresponding to the ABL1 protein were detected (data not shown). This may be due to the instability of the truncated protein or the lack of reactive epitopes for the anti-BL1 antibodies in the ABL1 protein.
Antibodies raised against the BR1 protein recognized a discrete ~30-kD band, the size predicted for this protein. This band was present in extracts of BR1 ( Figure 5A, lanes 6 to 8) and BLT.-.BR1 ( Figure 5B , lane 6) transgenic plants but not in control extracts ( Figure 5A , lane 5). BR1 in the transgenic extracts was also found to precisely comigrate with BR1 expressed in baculovirus-infected insect cells ( Figure SB, lanes  8 and 9) . The anti-BR1 antibodies cross-reacted with a few lower and higher molecular weight bands of unknown identity in the transgenic extracts; however, these bands (but not the 30-kD band) were also recognized by the preimmune sera (data not shown) and were often present in control extracts ( Figure 5A , lane 5). In tissue from BR1 plants, BR1 protein was found primarily in the cell membrane P30 fraction, with a lower amount also detected in the soluble S30 and cell wall P1 fractions (Figure 5A , lanes 6 to 8). In BL1::BR1 plants, BR1 protein was detected only in the cell membrane P30 fraction and not in the other two protein fractions ( Figure 5B, lanes 5 to 7) . The levels of BR1 were generally much lower in BL1::BR1 plants than in the lines that expressed BR1 alone (compare Figure  5B , lane 6 and Figure 5A , lane 7; data not shown). This is consistent with the RNA analysis, which indicated that BR1 was expressed at a lower level in BL1::BR1 plants compared to many of the BR1 plants. The absence of BR1 in the other fractions may thus reflect the lower levels of BR1 protein in these particular plant extracts.
Subcellular Localization of BR1 and BL1 in Infected Plants
We compared the subcellular localization of BL1 and BR1 in infected plants to that found in extracts of transgenic tobacco. Tobacco and pumpkin plants were infected with SqLCV-E and subjected to the same fractionation schemes described above. Similar to the localization in BL1 transgenic tobacco, BL1 protein was present primarily in the membrane fraction (P30) of infected pumpkin and tobacco tissues, as shown in Figure 6A . Lower amounts of BL1 were detected in the cell wall (P1) fraction, with very little detected in the S30 soluble fraction. In direct comparisons, BL1 was also found to be expressed in the SqLCV-infected tissues at comparable levels to BL1 in the transgenic BL1 and BL1::BR1 plants (data not shown).
The localization of BR1 in the SqLCV-infected tissues was also similar to that observed in the BR1 transgenic tobacco lines. BR1 was found predominantly in the P30 membrane fraction in infected tobacco tissue ( Figure 6B ), similar to the fractionation of BR1 in BR1 and BL1::BR1 plants. In infected pumpkin tissue, BR1 fractionated more heterogeneously, accumulating in all three fractions ( Figure 6B ). In general, SqLCV-infected pumpkin had higher levels of BR1 than SqLCVinfected tobacco and appeared to accumulate more BR1 in the soluble and cell wall fractions. However, the BR1 levels in infected pumpkin were similar to those found in BR1 transgenic plants (data not shown). The higher levels of BR1 protein or the presence of other viral proteins in the infected plants may contribute to its more heterogeneous distribution. Recently, von Arnim et al. (1993) reported the localization of the African cassava mosaic virus MPs in infected plants. Due to differences in fractionation procedures, their results cannot be directly compared to those reported here.
BR1 and BL1 Localize to Different Membrane Fractions
The localization of both BR1 and BL1 to a crude membrane fraction in both transgenic and infected tissues could suggest that BR1 and BL1 function together and perhaps even influence each other's subcellular distribution. To further localize the two MPs, we employed an aqueous two-phase partitioning method (Larsson, 1985; Bush, 1989) to separate plasma membrane from other cellular membranes. SqLCV-infected pumpkin tissue was fractionated and assayed by protein immunoblots for the presence of BL1 and BR1 in each separation phase. As shown in Figure 7 , BR1 was detected only with the other cellular membranes (Figure 7 , OM) and was not present in the plasma membrane fraction (Figure 7 , PM). In contrast, BL1
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DISCUSSION
Through genetic criteria, BL1 and BR1 in the bipartite geminiviruses have been assigned the roles of MPs. Mutations that disrupt either coding region prevent systemic infection without affecting viral replication and encapsidation (Brough et al., 1988; Etessami et al., 1988) . Thus, these two proteins are likely to participate in the cell-to-cell and systemic transport of the virus in the plant. As an approach to elucidating the infected pumpkin
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fractionated to the plasma membrane fraction (Figure 7 , PM). This distinct distribution of BR1 and BL1 suggests that their localization is independent of one another. To confirm the independent localization of BL1, we assayed membrane localization in BL1 transgenic tobacco. Similar to the results with infected tissue, BL1 localized primarily to the plasma membrane fraction, and only trace amounts of BL1 remained with the other cellular membranes (Figure 7) . The identity of the fractions was confirmed by ATPase and chlorophyll assays. The plasma membrane fractions were enriched 5-to 10-fold in the specific activity of the sodium vanadate-sensitive ATPase, as compared with the total membrane fraction (data not shown). In addition, the levels of chlorophyll were low to undetectable in the plasma membrane fraction and 20-to 40-fold higher in the other cellular membrane fraction (data not shown). These results indicate that BL1 localization is independent of BR1 and that BL1 localizes predominantly cc-BLl Aqueous two-phase partitioning was performed on membrane fractions from either SqLCV-infected pumpkin or transgenic tobacco line BL1-31. Immunoblotting was performed as detailed in the Figure 5 legend. The top panel was probed with anti-BR1 antisera, and the bottom panels were probed with antisera against BL1. S50 is the soluble fraction from the total cell extract. OM (other membrane) indicates that fraction of cellular membranes that are partitioned away from the plasma membrane. PM is the plasma membrane-containing fraction. Equal amounts of protein were loaded in the S50, OM, and PM lanes. Lanes marked BL1 and BR1 are total membrane fractions; however, they do not represent equivalent amounts of total protein and are merely included as reference markers for the specific BL1 and BR1 bands. Numbers to the side of each panel indicate protein molecular weight markers given in kilodaltons.
biochemical functions of the bipartite geminivirus MPs, as well as defining their respective contributions to viral infection, we generated transgenic tobacco plants expressing the SqLCV BR7-and BL7-encoded proteins. Our comparative analysis of plants expressing each SqLCV MP singly or together demonstrated that the expression of BL1 is sufficient to produce diseaselike symptoms, whereas the expression of BR1 has no apparent effects on the appearance or growth of tobacco.
Previous molecular genetic studies have shown that both viral movement and replication contribute to viral host range and pathogenicity in the bipartite geminiviruses (Lazarowitz, 1991; Lazarowitz et al., 1992) . Analyses of geminivirus MPs in the context of viral infection have further suggested that BL7 influences the symptom phenotype. The construction of chimeric B components from two different strains of TGMV demonstrated that the genomic segment encompassing the BL7 coding region and the untranslated upstream sequences from within the start of the common region to the start of BL7 is responsible for the differences in symptoms of these two TGMV strains (von Arnim and Stanley, 1992) . Although these findings suggested that BL1 is a determinant of symptom appearance, contributions of the common region sequences to replication could not be excluded. Intriguingly, in previous studies of TGMV, integration of the B component in transgenic petunia or tobacco plants (Rogers et al., 1986a; Elmer et al., 1988) was not sufficient to produce a symptomatic phenotype. However, in these studies, BR7 and BL7 expression was dependent on the endogenous viral promoters and thus was likely to be very weak without the benefit of amplification normally provided by replication and transcriptional transactivation (Sunter and Bisaro, 1992) in the presence of the A component. In addition, petunia is nota host for systemic TGMV infection, and this could also explain the lack of symptom production.
Our ability to express each of the SqLCV MPs under the control of the constitutive CaMV 35s promoter, independent of viral infection and in a host normally permissive for SqLCV infection, has clearly shown that BL7 both influences symptom production and, in fact, is sufficient for many of the phenotypic characteristics of SqLCV infection. Truncation of BL7 in the ABL7 transgenic plants does not produce a diseaselike phenotype and neither does the expression of the second SqLCV-E MP BR7. These results suggest that expression of full-length BL7 leads to the epinasty and mosaic phenotypes of the plants. The levels of BL1 protein are comparable in extracts of both transgenic and SqLCV-infected plants, and given the levels detected, the phenotype of the BL7 plants does not appear to be the result of a gross overexpression of BL1. In addition, the similar patterns of BL1 subcellular localization in extracts of transgenic and infected tissue suggest that BL1 interacts with the host plant in a similar manner in both cases to produce the leaf curl and mosaic phenotypes. It has been assumed that disease symptoms during geminivirus infection are the result of virus-induced necrosis in the phloem companion cells inhibiting general transport throughout the phloem (Goodman, 1981) . Our results demonstrate that the expression of BL1, and not necrosis due to viral replication, is responsible for the disease symptoms. This suggests that BL1 may interfere with cell-to-cell movement in the vascular system. Future ultrastructural and metabolic studies of these transgenic plants will address this issue. To our knowledge, SqLCV BL7 is the one clear example of a viral MP producing the appropriate symptoms when expressed in transgenic plants generated from a permissive host. There have been previous reports of other plant virus proteins expressed in transgenic plants, most notably gene VI of CaMV, which is a translational transactivator of viral genes (Baughman et al., 1988; Goldberg et al., 1989; Takahashi et al., 1989; Zijlstra and Hohn, 1992) , and the coat protein and MP of TMV (Abel et al., 1986; Deom et al., 1987) . In the experiments with the TMV proteins, neither the coat protein nor the 30-kD MP produced a visible phenotype in transgenic tobacco (Abel et al., 1986; Deom et al., 1987) . However, it has been reported that mutant TMV coat protein expressed in transgenic plants elicits a hypersensitive response (Culver and Dawson, 1991) . The expression of CaMV gene VI in transgenic tobacco generated from nonhost species for this virus produces chlorotic and mosaic leaves and stunted growth (Baughman et al., 1988; Goldberg et al., 1989; Takahashi et al., 1989) . These traits are similar to CaMV infection symptoms; however, these symptoms are not produced upon transformation of susceptible host species. In fact, gene VI expressed in hosts permissive for CaMV infection produced no abnormal phenotypes (Goldberg et al., 1989) . Hence, each of these CaMV and TMV genes, although they may be in some capacity associated with symptom development, is not sufficient to cause the disease phenotype in susceptible host plants.
What are the functions of the bipartite geminivirus MPs? The requirement for two MPs in these viruses suggests that there may be partitioning of movement functions between BL7 and BR7. One model for partitioning is that one MP participates in direct cell-to-cell movement in vascular cells, whereas the other is involved in long-distance (systemic) movement through the sieve elements. Our subcellular fractionation studies presented here and previous genetic studies are consistent with this model. Although both MPs are found in the microsomal membrane fraction, BL1 localizes predominantly to the plasma membrane, whereas BR1 fractionates with the other cellular membranes. In addition, BLl localizes to the cell wall fraction. These distinct subcellular localizations of BL1 and BR1 suggest that they function in different cellular compartments, perhaps in different steps in viral movement. The different phenotypes of the BL7 and 8/37 transgenic plants further demonstrate that BR1 and BL1 have distinct interactions in the plants. Previous studies of SqLCV have suggested that BR7 may be dispensable for cell-to-cell movement. A mutant SqLCV B component (BR") is able to amplify the SqLCV A component in agroinoculated tobacco leaf discs (Lazarowitz, 1991) . This is presumably accomplished by direct cell-to-cell movement within the leaf disc, increasing the number of cells in which the SqLCV A component replicates. However, BR*, which contains a missense mutation in BR7, is not able to infect tobacco systemically (Lazarowitz, 1991; lngham and Lazarowitz, 1993) . Based on these studies and the subcellular localization studies presented here, we suggest that BRI participates in long-distance (systemic) movement and not in cell-to-cell movement of the virus, and that BLI may be the MP responsible for cell-tocell spread. These predications are testable and currently being investigated.
Severa1 studies have suggested that long-distance and cellto-cell movement may constitute two separable functions (reviewed in Hull, 1991) . One such example is that of TMV. The TMV 30-kD protein is thought to participate in the cell-to-cell spread of the virus (Wolf et al., 1989; Citovsky et ai., 1990; Deom et al., 1990) . It has been shown that the TMV MP increases the size exclusion limits of plasmodesmata between mesophyll and bundle sheath cells but not between bundle sheath and phloem parenchyma cells (Ding et al., 1992) . Because TMV must reach the phloem for systemic movement, Ding et al. (1992) have suggested that the TMV coat protein may participate in the movement of the virus from the bundle sheath cells into the vascular tissue by cooperating with the 30-kD M!? Studies of TMV coat protein mutants have also implicated the coat protein as having a role in systemic movement (Dawson et al., 1988; Saito et al., 1990) . Thus, long-distance movement of TMV may require other viral proteins in addition to the M!? In contrast to the requirements of most plant viruses, the coat protein is not essential for systemic infection by the bipartite geminiviruses. Studies of TGMV and African cassava mosaic virus found that mutants lacking the coat protein gene could systemically infect N. benthamiana and cause disease, although the symptoms were delayed and attenuated Klinkenberg et al., 1989) . Thus, as suggested in the model discussed above, BRI may function in long-distance viral systemic movement, partially able to carry out the process in the absence of coat protein and facilitating this when encapsidated virions are present. It is also possible that the BR1 MP is the sole determinant for long-distance movement and that differences observed in the presence or absence of the coat protein simply reflect the protection of the viral ssDNA genome from degradation when associated with coat protein.
We had anticipated that, as shown with TMV (Deom et al., 1987; Holt and Beachy, 1991) , plants expressing the SqLCV MPs would complement viruses mutated in either of these genes. Unexpectedly, preliminary studies failed to detect complementation for any of our lines tested to date (E. Pascal and S. G. Lazarowitz, unpublished results). This does not seem to be related to the functional integrity of BL7 and BR7 in the transgenic plants, as we have obtained similar negative results with transgenic plants expressing other SqLCV proteins such as the AL2 transactivator or the coat protein (A. Sanderfoot and S. G. Lazarowitz, unpublished results) . Thus, it is possible that the timing of expression for the viral proteins is critical and that the constitutive expression in the transgenic plants cannot correctly integrate with the viral program. It is also POSsible that given the potential for broad expression of the transgenes under the control of the CaMV promoter (Odell et al., 1985) , compared to the phloem limitation of the virus (Goodman, 1981; Matthews, 1991) , sufficient levels of viral proteins may not be expressed in the correct cell types for complementation. More precise localization of BR1 and BL1 in the transgenic lines and the use of tissue-specific promoters will address these points and have important implications for effective strategies to engineer plants resistant to infections by geminiviruses and perhaps other phloem-limited viruses.
Although many questions remain to be resolved, the expression of BR7 and BL7 MPs in transgenic plants independent of viral replication and infection has provided new insights into the roles of these MPs. We have clearly demonstrated that BL7 is responsible for the production of phenotypic changes characteristic of viral disease symptoms and the specific association of the BL1 protein with the cell membrane and cell wall fractions. In addition, the distinct localization of BL1 and BR1 to separate membrane fractions along with the normal appearance of BRI-expressing transgenic tobacco indicate that the BLI and BRI MPs may have distinct and separablefunctions. Our transgenic plants will serve as useful tools to now address the multitudeof possibilitiesfor MPfunction. The abilityto perturb the host in a manner similar to that of viral infection by simply expressing the BL7 MP provides a new approach to address viral-host interactions and to further define the effects of viral infection on normal cellular processes. In particular, these transgenic plants open the way to identifying host proteins involved in the regulation of transport in the plant.
METHODS
Construction ot Movement Protein Expression Vectors
BL7 was cloned as an Aval-Ndel fragment between nucleotides 2575 and 1442 of the extended host range squash leaf curl virus (SqLCV-E) B component (Lazarowitz and Lazdins, 1991) . After blunting with the Klenow fragment of Escherichia coli DNA polymerase I and ligation to EcoRl linkers (Bethesda Research Laboratories), this fragment was cloned into the unique EcoRl site of pMON530 (Rogers et al., 1987) to create pSQBL1E. For the creation of ABL7, the EcoRl fragment from pSQBLlE was cloned into the EcoRl site of pGEM7Z-(Stratagene) to create pGBL1. This plasmid was then cut with Xbal, blunt ended with the Klenow fragment, and religated to create a stop codon after amino acid 193 in BL1. This BLI truncation was then cloned back into the Smal site of pMON530 as a Pvull fragment to create pSQABL1. BR7 was cloned in two ways, as an EcoRI-Aval fragment (nucleotides 632 to 1669 of SqLCV-E B component) and as an Mboll-Aval fragment (nucleotides 579 to 1669). This was based on sequence data that identified two in-frame methionines 13 amino acids apart. Subsequent SI mapping has demonstrated that the second methionine is the true start codon (S.G. Lazarowitz, unpublished data) . Both fragments were blunt ended with the Klenow fragment and then ligated to Bglll linkers (Bethesda Research Laboratories) and cloned into the unique Bglll site in pMON530 to create pSQBR1E. In a similar manner, BR7 was cloned into the unique Bglll site of pMON921, fusing it with the enhanced cauliflower mosaic virus (CaMV) 35s promoter (Kay et al., 1987) . This expression cassette was transferred as a Notl fragment into the unique Notl site in pSQBLlE to create pSQBL1::BRIE.
Expression cassettes constructed using either 6/31 fragment gave identical results in transformed Nicotiana benthamiana (hereafter referred to as tobacco).
the appropriate 3*P-labeled DNA probe (Feinberg and Vogelstein, 1984) .
Plant Transformation
The expression vectors were transferred to Agrobacterium tumefaciens carrying the disarmed plasmid TiT37SE by the triparental mating procedure (Rogers et al., 1986b) . These Agrobacterium strains were used to transform leaf explants of tobacco by the methods of Rogers and coworkers (1986) with the following modifications: (1) explants from young sterile seedlings were wounded with blunt forceps and the nurse layer was omitted, and (2) calli and shoots were selected on kanamycincontaining media continuously throughout the regeneration procedure, with transfer to fresh plates every 3 to 4 weeks. 6L1 and ABL7 plants were derived by transformation with Agrobacterium carrying pSQBLIE and pSQABL1, respectively. 6R7 lines were generated from tobacco transformed with pSQBR1E. Lines BR7-9,6R7-74,6R7-78,BR7-34, and BR7-33 contained 6R7 starting at nucleotide 579. All other 6R7 lines contained 6R7 starting at nucleotide 632. BL7::BRl lines were generated from tobacco transformed with pSQBL1::BRlE. Lines BL7::6R7-70, BL7::BR7-20, and BLl::BR1-57 through BL7::BR7-59 contained BR7 starting at nucleotide 579. All other BL7::BR7 lines contained BR7 starting at nucleotide 632.
Polymerase Chain Reaction Analysis
Leaves (4 to 2 cm) were collected from primary transformants and F, seedlings. DNA was extracted with cetyltrimethylammonium bromide and 2 pL (of 50 pL total) was used as a substrate for polymerase chain reaction (PCR) analysis with specific primers (McGarvey and Kaper, 1991) . The primers used are as follows: pMON530 cassette, 5'-CTGAAATCACCAGTCTCTCTC-3' (upstream) and 5'-TGCCAAATG-TTTGAACGATC-3' (downstream); pMON921 Notl cassette, 5'-TGG-AGAGGACACGCTGA3' (upstream) and 5'-GTCGAAACCGATGATACG-3' (downstream). DNA from each sample was fractionated on 1.4% agarose gels, transferred to nylon membranes (Hoeffer), and hybridized with BR1-or BL7-specific probes (Southern, 1975; Reed and Mann, 1985) . The DNA probes were labeled with U -~~P -~C T P by the random hexamer priming method (Feinberg and Vogelstein, 1984) .
RNA Analysis
Approximately 100 mg of leaf tissue was ground in liquid nitrogen in an Eppendorf tube with a Kontes pestle. RNAextraction was performed using the method of Verwoerd et al. (1989) . Concentrations were approximated by spectrophotometer readings at 1 = 260 nm. Twenty micrograms of RNA was fractionated on 1.5% agarose gels containing formaldehyde and transferred to nylon membranes (Ausubel et al., 1989) . Sizes were standardized to RNA markers (GIBCO BRL). Transfer and equal loading of samples were confirmed by methylene blue staining of the nylon following blotting. RNA blots were preincubated for 1 hr at 42% in 5 x SSC (1 x SSC is 0.15 M sodium chloride, 0.015 M sodium citrate) containing 1% SDS, 5 x Denhardt's solution (1 x Denhardfs solution is 0.02% Ficoll, 0.02% polyvinylpyrrolidine, and 0.02% BSA), 100 mglmL of denatured salmon sperm DNA, and 50% formamide. The blots were then hybridized at 42OC in the same buffer with the addition of dextran sulfate to a final concentration of 10% and Subcellular Fractionation Two grams of leaf tissue was ground to a fine powder under liquid nitrogen. Protein extraction and fractionation followed the procedure of Deom et al. (1990) , with the following modifications: (1) extensive grinding in liquid nitrogen was substituted for the first step of the mechanical grinding, and (2) the tissues were not further ground after the addition of Triton X-100. Membrane and cell wall pellets were resuspended in 700 pL and 3 mL, respectively, of sample buffer (60 mM Tris-HCI, pH 8, 2.3% SDS, 5% P-mercaptoethanol, 10% glycerol, and 0.1% bromophenol blue). The volume of the soluble S30 fraction was 10 mL. Twenty microliters of each fraction was loaded for gel analysis of each sample, except where otherwise noted. Protein amounts were approximated by staining of SDS-polyacrylamide gels with Coomassie brilliant blue R 250. lnfected Curcurbita maxima (var Big Max; hereafter referred to as pumpkin) tissue was harvested at 15 days postinfection. lnfected tobacco tissue was harvested at 22 days postinfection. Pumpkin and tobacco seedlings were infected with cloned genomic components of SqLCV-E by agroinoculation, as described previously (Lazarowitz and Lazdins, 1991) .
Total cell extracts of baculovirus-expressed BL1 and BR1 in infected Sf9 cells were used as references for the size of each vira1 movement protein (MP). For this purpose BL7 and 8/31 were cloned as transcriptional fusions (nucleotides 2575 to 1442 and nucleotides 679 to 1669, respectively) into the vector pVL1393 (Summers and Smith, 1987) . All manipulations followed the procedures of Summers and Smith (1987) .
Two-Phase Separation of Membrane Fractions
For partitioning membrane fractions, membranes were prepared according to the method of Bush (1989) from fresh, unfrozen SqLCVinfected pumpkin (40 g of tissue at 7 days postinfection) and transgenic BL1 tobacco ( 20 g of fully expanded leaf tissue from BL7-37). Plasma membranes were separated using the aqueous two-phase partition method (Larsson, 1985) under the conditions described by Bush (1989) . ATPase and chlorophyll assays followed the methods of Bush (1989) . Protein was quantitated using the Bio-Rad protein assay. Equal amounts of protein from each fraction were used for SDS-PAGE analysis.
Protein Gels and lmmunoblots
Proteins were separated by SDS-PAGE on 12% discontinuous buffer gels (Laemmli, 1970) and transferred to nitrocellulose in 20 mM sodium phosphate, pH 6.8. BL1 and BR1 were detected by rabbit polyclonal antisera raised against bacterial-expressed BLI or BRI, respectively (see below), followed by incubation with alkaline phosphatase-conjugated anti-rabbit antibodies (Promega). Following each antibody incubation, washes were performed with 10 mM Tris-HCI, pH 8.0, 150 mM NaCI, 0.05% Tween-20. Nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate p-toludine salt were used for color development (Harlow and Lane, 1988) .
Antibodies directed against BLI and BR1 were raised against translational fusions of BL1 (amino acids 11 to 279) and BR1 (amino acids 12 to 233) to the N-terminal12 amino acids of T7 gene 10 in the pET-3 vectors (pET9a and pET-3b, respectively) (Studier et al., 1990 ) expressed in E. coli BL21 (DE3) pLysS. Growth and induction followed the methods of Studier et al. (1990) . Cell pellets were washed and sonicated in HEMG (25 mM Hepes-KOH, pH 7.6, 0.1 mM EDTA, 12.5 mM MgC12, 10% glycerol). Following centrifugation at lO,OOOg, the pellet was washed successively in HEMG with 0.05% Triton X-100, HEMG with 2 M urea, and HEMG with 0.1% SDS. The final pellet was resuspended in sample buffer and loaded onto 10 to 15% acrylamide gradient gels for SDS-PAGE. Protein was visualized by Coomassie brilliant blue R 250 staining in water. The BL1 or BR1 protein band was excised and ground to a fine powder in liquid nitrogen. Rabbits were injected with 0.5 to 1.0 mg of protein for the initial injection and subsequent boosts. The antibody pellet from a 50% ammonium sulfate precipitation was used at 1:2000 dilution for all protein immunoblots.
